Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: The Stanislas cohort

被引:130
作者
Siest, G
Visvikis, S
Herbeth, B
Gueguen, R
Vincent-Viry, M
Sass, C
Beaud, B
Lecomte, E
Steinmetz, J
Locuty, J
Chevrier, P
机构
[1] Ctr Med Prevent, F-54501 Vandoeuvre Les Nancy, France
[2] Univ Nancy 1, Fac Pharm, Unite Propre Rech Enseignement Super, Nancy, France
关键词
familial study; longitudinal study; cardiovascular disease; gene-environment interactions;
D O I
10.1515/CCLM.1998.007
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The main objective of the Stanislas cohort is to study the role and the contribution of genetic and environmental factors to cardiovascular status. We plan: a) to describe the degree of association of a large number of cardiovascular risk indicators with cardiovascular endpoints, b) to evaluate the contribution of genetic and that of environmental factors to this association, c) to follow the evolution of these risk indicators during a period of at least ten years, d) to search for the determinants influencing this evolution. The principal variables studied are: a) blood pressure, cardiac mass, and wall thickness of carotid and femoral arteries, b) obesity and fat mass, c) indicators of lipid metabolism, d) genetic polymorphisms of several cardiovascular risk candidate genes, e) food, tobacco and alcohol consumption, f) consumption of drugs and anti-oxidant vitamins. Between September 1993 and August 1995, 1006 families consisting of the two biological parents with at least two children were recruited totalling 4295 individuals. This cohort will be followed up until 2004. There will be two health examinations five and ten years after the initial examination. A bank of blood samples (serum and plasma) in liquid nitrogen and DNA (-80 degrees C) has been established.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 32 条
[1]  
[Anonymous], 1993, MOL EPIDEMIOLOGY PRI
[2]   THE USE OF MEASURED GENOTYPE INFORMATION IN THE ANALYSIS OF QUANTITATIVE PHENOTYPES IN MAN .2. THE ROLE OF THE APOLIPOPROTEIN-E POLYMORPHISM IN DETERMINING LEVELS, VARIABILITY, AND COVARIABILITY OF CHOLESTEROL, BETA-LIPOPROTEIN, AND TRIGLYCERIDES IN A SAMPLE OF UNRELATED INDIVIDUALS [J].
BOERWINKLE, E ;
VISVIKIS, S ;
WELSH, D ;
STEINMETZ, J ;
HANASH, SM ;
SING, CF .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1987, 27 (03) :567-582
[3]   Apolipoprotein E genotype epsilon 4/epsilon 2 in the STANISLAS cohort study - Dominance of the epsilon 2 allele? [J].
Bohnet, K ;
RegisBailly, A ;
VincentViry, M ;
Schlenck, A ;
Gueguen, R ;
Siest, G ;
Visvikis, S .
ANNALS OF HUMAN GENETICS, 1996, 60 :509-516
[4]   GENETIC-BASIS OF LIPOPROTEIN DISORDERS [J].
DAMMERMAN, M ;
BRESLOW, JL .
CIRCULATION, 1995, 91 (02) :505-512
[5]  
ECKERSON HW, 1983, AM J HUM GENET, V35, P214
[6]  
Esterbauer H, 1997, Adv Pharmacol, V38, P425
[7]  
Georges JL, 1996, GENET EPIDEMIOL, V13, P179
[8]   THE EFFECT OF VARIATION IN THE APOLIPOPROTEIN-B GENE ON PLASMA-LIPID AND APOLIPOPROTEIN-B LEVELS .1. A LIKELIHOOD-BASED APPROACH TO CLADISTIC-ANALYSIS [J].
HALLMAN, DM ;
VISVIKIS, S ;
STEINMETZ, J ;
BOERWINKLE, E .
ANNALS OF HUMAN GENETICS, 1994, 58 :35-64
[9]  
HEGELE RA, 1992, MOL CELL BIOCHEM, V113, P177
[10]   The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data (vol 123, pg 860, 1995) [J].
Jha, P ;
Flather, M ;
Lonn, E ;
Farkouh, M ;
Yusuf, S .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (10) :934-934